✦ LIBER ✦

Apolipoprotein E dose-dependent modulation of β-amyloid deposition in a transgenic mouse model of Alzheimer’s disease

✍ Scribed by Ronald B. DeMattos

Book ID: 111639757
Publisher: Humana Press Inc
Year: 2004
Tongue: English
Weight: 90 KB
Volume: 23
Category: Article
ISSN: 0895-8696
DOI: 10.1385/jmn:23:3:255

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gender dependent APP processing in a tra

Gender dependent APP processing in a transgenic mouse model of Alzheimer’s disease

✍ S. Schäfer; O. Wirths; G. Multhaup; T. A. Bayer 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 171 KB

The spatial pattern of β-amyloid (Aβ) de

The spatial pattern of β-amyloid (Aβ) deposits in Alzheimer's disease patients is related to apolipoprotein genotype

✍ R.A. Armstrong; N.J. Cairns; P.L. Lantos 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

Transthyretin Accelerates Vascular Aβ De

Transthyretin Accelerates Vascular Aβ Deposition in a Mouse Model of Alzheimer's Disease

✍ Henny Wati; Takeshi Kawarabayashi; Etsuro Matsubara; Ayumi Kasai; Takae Hirasawa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Coenzyme Q10 Reduces β-Amyloid Plaque in

Coenzyme Q10 Reduces β-Amyloid Plaque in an APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease

✍ Xifei Yang; George Dai; Geng Li; Edward S. Yang 📂 Article 📅 2009 🏛 Humana Press Inc 🌐 English ⚖ 160 KB

Working memory impairment in a transgeni

Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease

✍ L. Lovasic; H. Bauschke; C. Janus 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

MRI assessment of neuropathology in a tr

MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease

✍ Joseph A. Helpern; Sang-Pil Lee; Maria F. Falangola; Victor V. Dyakin; Adam Boga 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

## Abstract The cerebral deposition of amyloid β‐peptide, a central event in Alzheimer's disease (AD) pathogenesis, begins several years before the onset of clinical symptoms. Noninvasive detection of AD pathology at this initial stage would facilitate intervention and enhance treatment success. In